Analyst Ratings For Edwards Lifesciences Corporation (NYSE:EW)
Today, Stifel Nicolaus reiterated its Buy rating on Edwards Lifesciences Corporation (NYSE:EW) with a price target of $130.00.
There are 1 sell rating, 5 hold ratings, 15 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on Edwards Lifesciences Corporation (NYSE:EW) is Buy (Score: 2.73) with a consensus target price of $116.81 per share, a potential 1.04% upside.
Some recent analyst ratings include
- 7/27/2017-Stifel Nicolaus Reiterated Rating of Buy .
- 6/28/2017-Canaccord Genuity Reiterated Rating of Buy.
- 5/30/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- 5/16/2017-Goldman Sachs Group, Inc. (The) initiated coverage with a Conviction-Buy rating.
Recent Insider Trading Activity For Edwards Lifesciences Corporation (NYSE:EW)
Edwards Lifesciences Corporation (NYSE:EW) has insider ownership of 2.13% and institutional ownership of 83.96%.
- On 6/29/2017 Donald E. Bobo, Jr., VP, sold 5,600 with an average share price of $117.15 per share and the total transaction amounting to $656,040.00. View SEC Filing
- On 6/7/2017 Michael A. Mussallem, CEO, sold 32,900 with an average share price of $118.05 per share and the total transaction amounting to $3,883,845.00. View SEC Filing
- On 5/31/2017 Patrick B. Verguet, VP, sold 10,000 with an average share price of $114.88 per share and the total transaction amounting to $1,148,800.00. View SEC Filing
- On 5/19/2017 Dylan Sidoo, Director, bought 25,000 with an average share price of $0.11 per share and the total transaction amounting to $2,750.00.
- On 5/19/2017 Patrick B. Verguet, VP, sold 22,631 with an average share price of $113.16 per share and the total transaction amounting to $2,560,923.96. View SEC Filing
- On 5/15/2017 Patrick B. Verguet, VP, sold 11,500 with an average share price of $111.64 per share and the total transaction amounting to $1,283,860.00. View SEC Filing
- On 5/8/2017 Donald E. Bobo, Jr., VP, sold 19,100 with an average share price of $110.34 per share and the total transaction amounting to $2,107,494.00. View SEC Filing
Recent Trading Activity for Edwards Lifesciences Corporation (NYSE:EW)
Shares of Edwards Lifesciences Corporation closed the previous trading session at 115.61 down -0.02 -0.02% with 2,168,817 shares trading hands.